Pediatric Rheumatology

pediatric rheumatology banner

Latest News

Higher Biologic Drug Survival in JIA With Younger Age at Treatment Initiation

Higher Biologic Drug Survival in JIA With Younger Age at Treatment Initiation

Rates of biologic drug survival and suspension by remission were both higher in those who initiated biologic treatment at <16 years.

Rituximab May Be Effective in Children With Treatment-Resistant Juvenile Idiopathic Arthritis

Rituximab May Be Effective in Children With Treatment-Resistant Juvenile Idiopathic Arthritis

Rituximab may be an effective treatment option for many patients with juvenile idiopathic arthritis who did not respond to other therapies.

Determining Risk for New-Onset Uveitis in Juvenile Idiopathic Arthritis

Determining Risk for New-Onset Uveitis in Juvenile Idiopathic Arthritis

Researchers sought to quantify the annual incidence of new-onset uveitis following JIA diagnosis and identify associated risk factors.

Psychological Flexibility Improves Resilience in Children With Juvenile Idiopathic Arthritis and Their Parents

Psychological Flexibility Improves Resilience in Children With Juvenile Idiopathic Arthritis and Their Parents

Psychological flexibility in children with juvenile idiopathic arthritis and in their parents may represent resilience factors for dealing with pain and disability associated with the condition.

Canakinumab Treatment Led to Substantial Glucocorticoid Reduction in JIA

Canakinumab Treatment Led to Substantial Glucocorticoid Reduction in JIA

Researchers evaluated the long-term efficacy and safety of canakinumab in patients with active systemic juvenile idiopathic arthritis.

Humira Approved for the Treatment of Pediatric Uveitis

Humira Approved for the Treatment of Pediatric Uveitis

The approval was based on data from a randomized, double-masked, placebo-controlled study of 90 pediatric patients aged 2 to < 18 years with active JIA-associated non-infectious uveitis.

Clinical Features Identified for Localized Scleroderma in Children

Clinical Features Identified for Localized Scleroderma in Children

Researchers conducted a multicenter prospective study to identify clinical features characteristic of localized scleroderma in children.

Original vs Expanded Disease Activity Scoring System in JIA Examined

Original vs Expanded Disease Activity Scoring System in JIA Examined

For a more precise assessment of disease activity and treatment effectiveness in individuals with JIA, inclusion of MCP joints should be considered in the scoring system.

Tacrolimus Possibly Beneficial Long Term in Lupus Nephritis

Tacrolimus Possibly Beneficial Long Term in Lupus Nephritis

Over a 5-year period, the drug was well tolerated and associated with significant declines in urinary protein-creatinine ratio and mean prednisolone dose.

Transitioning to Adult Health Care: Predictors of Preparedness in Adolescents With Arthritis

Transitioning to Adult Health Care: Predictors of Preparedness in Adolescents With Arthritis

Female gender, older age, and higher patient activation scores predicted transition readiness in adolescent patients with arthritis.

Sign Up for Free e-newsletters